|
| 35032963 | COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop. | Altex | 2022 |
| 36280152 | REACHing for solutions: Essential revisions to the EU chemicals regulation to modernise safety assessment. | Regulatory Toxicology and Pharmacology | 2022 |
| 34389358 | Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients. | Regul Toxicol Pharmacol | 2021 |
| 34109416 | A Systematic Review to Compare Chemical Hazard Predictions of the Zebrafish Embryotoxicity Test With Mammalian Prenatal Developmental Toxicity. | Toxicol Sci | 2021 |
| 33837437 | Applying evidence-based methods to the development and use of adverse outcome pathways | ALTEX | 2021 |
| 33662477 | Re: A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU - A short communication. | Regulatory Toxicology and Pharmacology | 2021 |
| 34147625 | The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays. | Reproductive Toxicology | 2021 |
| 34095051 | Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. | Frontiers in Public Health | 2021 |
| 30953865 | Exploring new technologies in biomedical research. | Drug Discovery Today | 2019 |
| 30332685 | Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways. | ALTEX | 2019 |
| 30045572 | Harvesting the promise of AOPs: An assessment and recommendations. | Science of the Total Environment | 2018 |
| 29870792 | Recommendations toward a human pathway-based approach to disease research. | Drug Discov Today | 2018 |
| 30240875 | Parkinson's disease research: adopting a more human perspective to accelerate advances. | Drug Discovery Today | 2018 |
| 27989722 | Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations. | Drug Discov Today | 2017 |
| 28543973 | Advancing the adverse outcome pathway framework-An international horizon scanning approach. | Environ Toxicol Chem | 2017 |
| 27121921 | A randomised, double-blinded clinical study on the efficacy of multimedia presentation using an iPad for patient education of postoperative hip surgery patients in a public hospital in Singapore. | Singapore Medical Journal | 2017 |
| 26861067 | A look into the future of ALS research. | Drug Discovery Today | 2016 |
| 26500288 | Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence. | Toxicol Sci | 2015 |
| 26523530 | Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research. | Environ Health Perspect | 2015 |
| 24535319 | Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action. | ALTEX | 2014 |
| 24114257 | Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program. | ALTEX | 2014 |
| 24151143 | The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program. | Birth Defects Research Part B - Developmental and Reproductive Toxicology | 2014 |
| 24127042 | Pathways of Toxicity. | ALTEX | 2014 |
| 24954301 | Pathway-based toxicity: history, current approaches and liver fibrosis and steatosis as prototypes. | Altex | 2014 |
| 24773450 | Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing. | SAR and QSAR in Environmental Research | 2014 |
| 23945500 | Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. | Toxicological Sciences | 2013 |
| 23033452 | Animal use and lessons learned in the U.S. High Production Volume Chemicals Challenge Program. | Environmental Health Perspectives | 2012 |
| 21642633 | Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program. | Toxicological Sciences | 2011 |
| 21624455 | A discussion of the impact of US chemical regulation legislation on the field of toxicity testing. | Toxicology in Vitro | 2011 |
| 19079693 | Longer rodent bioassay fails to address 2-year bioassay's flaws. | Environmental Health Perspectives | 2008 |
| 16933308 | Zebrafish as a model for developmental neurotoxicity testing. | Birth Defects Research Part A - Clinical and Molecular Teratology | 2006 |
| 15043944 | T cells and the thymus in developing zebrafish. | Developmental and Comparative Immunology | 2004 |
| 15464224 | Expression of the winged helix/forkhead gene, foxn4, during zebrafish development. | Developmental Brain Research | 2004 |
| 23045087 | Zebrafish: an animal model for toxicological studies. | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | 2003 |
| 11748838 | Ikaros expression as a marker for lymphoid progenitors during zebrafish development. | Developmental Dynamics | 2001 |
| 14517415 | Zebrafish angiogenesis: a new model for drug screening. | Angiogenesis | 1999 |
| 10213388 | Early hematopoiesis and developing lymphoid organs in the zebrafish. | Developmental Dynamics | 1999 |
| 10471489 | Artificial chromosome transgenesis reveals long-distance negative regulation of rag1 in zebrafish. | Nature Genetics | 1999 |
| 9851360 | Sequence of the rag1 and rag2 intergenic region in zebrafish (Danio rerio). | | 1998 |
| 9070331 | Expression of zebrafish rag genes during early development identifies the thymus. | Developmental Biology | 1997 |
| 9089097 | Characterization and expression of the recombination activating genes (rag1 and rag2) of zebrafish. | Immunogenetics | 1997 |
| 9488050 | Sequence and expression pattern of J chain in the amphibian, Xenopus laevis. | Molecular Immunology | 1997 |
| 8455635 | A complex regulatory element from the yeast gene ENO2 modulates GCR1-dependent transcriptional activation. | Molecular and Cellular Biology | 1993 |
| 2201905 | Multiple factors bind the upstream activation sites of the yeast enolase genes ENO1 and ENO2: ABFI protein, like repressor activator protein RAP1, binds cis-acting sequences which modulate repression or activation of transcription. | Molecular and Cellular Biology | 1990 |
| 2823119 | Isolation and physical characterization of three essential conidiation genes from Aspergillus nidulans. | Molecular and Cellular Biology | 1987 |